CTRI/2024/04/065467
Not Yet Recruiting
Phase 2
Preclinical and Clinical Evaluation of the efficacy of Siddha Classical decoction formulation Aavarai Kudineer in Management of Diabetic Nephropathy - NI
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications
- Sponsor
- ot Applicable
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult men women transgender 40 years to 85 years of age
- •Diabetic kidney disease DKD
- •diagnosis of T2DM
- •eGFR more than 45 mL/min/1\.73 m2(20\)
- •ACR(spot microalbumin) more than 30 mg/g
Exclusion Criteria
- •Serum potassium more than 5\.5 mmol per L
- •2\. Haemoglobin A1c more than 10\.5 percentage
- •3\. Pregnancy breastfeeding or intention to become pregnant during the course of the study
- •4\. Any other medical condition or clinically relevant abnormal findings in physical examination laboratory results or electrocardiogram (ECG) during screening that in the opinion of the investigator may compromise the safety of the subject in the study, reduce the subjects ability to participate in the study, or interfere with evaluation of the investigational product.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 2
Dashang aerosol spray in operated piles pain managementCTRI/2022/06/043585PARUL INSTITUTE OF AYURVEDA
Active, Not Recruiting
Phase 1
Evaluation of the safety and efficacy of the product in subjects experiencing hair lossCTRI/2018/03/012303Dabur Research Foundation
Completed
N/A
Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasmsmyeloproliferative neoplasmsJPRN-UMIN000031519Department of Hematology, Juntendo University School of Medicine110
Recruiting
Early Phase 1
Clinical evaluation of the efficacy and safety of Huayu Tongbi Fomular on rheumatoid arthritisRheumatoid ArthritisITMCTR2024000092Guangdong Provincial Hospital of Chinese Medicine
Completed
Phase 3
Clinical evaluation of the safety and effectiveness of Excilor 2-in-1 Wart Treatment in the treatment of warts on the hands and feetISRCTN39469406Medical Brands66